Porton Down’s archive was opened up for a study into the health of the human volunteers in the nerve agent testing programme.

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

Sonic is in a strong financial position. Free cash flow conversion of earnings before acquisition spending has averaged 94% over the last 5 years and has allowed Sonic to quickly repay the debt ...